Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA working on COVID-19 during closure on 27 April 2021 23 Aprile 2021 News Corporate COVID-19 Clinical Trials Information System reaches major milestone towards go-live and application of the Clinical Trial Regulation 21 Aprile 2021 News Human Clinical trials COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets 20 Aprile 2021 News Human COVID-19 Vaccines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 April 2021 16 Aprile 2021 News Veterinary Medicines EMA starts review of VIR-7831 for treating patients with COVID-19 15 Aprile 2021 News Human COVID-19 Medicines AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets 14 Aprile 2021 News Human COVID-19 Vaccines COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues 14 Aprile 2021 News Human COVID-19 Vaccines IT systems intermittently unavailable from 16 to 18 April 2021 14 Aprile 2021 News Corporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021 9 Aprile 2021 News Human COVID-19 Pharmacovigilance Referrals AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets 7 Aprile 2021 News Human COVID-19 Vaccines 1 … 62 63 64 65 66 Page 66 of 379 67 68 69 70 … 379
Clinical Trials Information System reaches major milestone towards go-live and application of the Clinical Trial Regulation 21 Aprile 2021 News Human Clinical trials
COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets 20 Aprile 2021 News Human COVID-19 Vaccines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 April 2021 16 Aprile 2021 News Veterinary Medicines
EMA starts review of VIR-7831 for treating patients with COVID-19 15 Aprile 2021 News Human COVID-19 Medicines
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets 14 Aprile 2021 News Human COVID-19 Vaccines
COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues 14 Aprile 2021 News Human COVID-19 Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021 9 Aprile 2021 News Human COVID-19 Pharmacovigilance Referrals
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets 7 Aprile 2021 News Human COVID-19 Vaccines